Patent ID: 6245788
Filing Date: 2001-06-12
Classification: A61K,A61P,Y02A

Abstract:
A method of inhibiting infection by HIV virus comprising administering to a patient in need thereof a therapeutically effective amount of a (5-aryl-1,2,4-thiadiazol)-3-yl thiourea derivative or a (5-aryl-1,2,4-thiadiazol)-3-yl urea derivative having the formula: ##STR6##wherein, X is oxygen or sulfur;R is hydrogen or alkyl having from 1 to 3 carbon atoms;n is 0 to 4; andR.sub.1 is independently selected from the group consisting of hydrogen, alkyl having from 1 to 7 carbon atoms, chloro, bromo, fluoro, oxychloro, and alkoxy having the formula --O(CH.sub.2).sub.y CH.sub.3 wherein y is from 1 to 6,for a period of time sufficient to build up immunity to infection with HIV virus.